In 2019, a total of nearly four million beverage cans containing cannabis were sold in the USA, according to FOOD DIVE magazine. In Canada, on the other hand, cannabis-containing beverages were only legalized at the beginning of this year. Despite the smaller population – nearly 40 million people live in Canada compared to 330 million in the U.S.
Canopy Growth has already sold more than 1.5 million beverages since the launch of its products in March 2020 and despite competition from other manufacturers in Canada, according to Andrew Rapsey, Global Head of Beverage at Canopy in an interview with FOOD DIVE.
Read more about the partnership between Canopy Growth and BioSteel and find the latest cannabis news with the Hemp.im mobile app.
Canopy Growth is a success story – and wants to achieve even more with beverages
The figures reflect the success that has accompanied Canopy Growth throughout its history: Founded in 2013, the Canadian company claims to be the first company in North America to publicly and legally trade its cannabis products in 2014.
Canopy Growth was the first company in the industry to be listed on the Toronto and New York Stock Exchanges, and in mid-2019 was also the first company in the industry to be listed on the global S&P/TSX 60 index, one of the most important indices of the Canadian stock exchange. Net revenues in the fiscal year 2020 amounted to $298 million (CA$399 million).
All manufactured products are sold through brands that are already established and trusted by customers, as Canopy Growth states on its website. This includes Martha Stewart, who promotes and sells CBD oils and wellness products for the company. This year in Canada, the company’s successful cannabis-containing beverages have now been added to the Canopy range. “The fact that we have actually captured almost half the Canadian market in such a short time […] is really exciting for us and we will certainly be working flat out on our beverage portfolio,” Rapsey told FOOD DIVE in September.
The US beverage market is to be entered thanks to the agreement with BioSteel
According to Rapsey, the goal for the next two to three years is to capture more than 50 percent of the cannabis beverage market in Canada – but also to establish the Canopy Growth beverages in the USA.
First, however, the company is expanding its involvement in another area of the beverage market: in 2019, Canopy Growth acquired a majority stake in BioSteel Sports Nutrition, another Canadian company. BioSteel is a manufacturer of nutritional products for athletes, founded in 2009, which this year launched a new range of sugar-free, natural drinks.
Already in mid-October, just under a month after Rapsey’s statement that intensive work on the beverage portfolio was underway, a press release by Canopy Growth and BioSteel announced cooperation between BioSteel and two major beverage suppliers: Manhattan Beer and Reyes Beer Division will supply the new BioSteel drinks in New York, California, Florida and other regions of the U.S., thus boosting the distribution of the drinks in the U.S.
This collaboration expands Canopy Growth’s scope of business and could facilitate the establishment of the company’s cannabis beverages in the United States. However, Rapsey has not yet named an exact date when the step into the USA will be made.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in finanzen.net, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
4 trends transforming the world of venture capital
What lies ahead for conventional venture capital companies in the world of cryptocurrencies is not clear right now. Yet, it...
How are ESG company news deciphered with Artificial Intelligence
Thanks to the incredible progress in artificial intelligence (AI) observed in recent years, and more specifically in natural language processing...
5 easy ways to start an online business from home
Affiliate marketing is one of the most preferred methods of monetization of a blog. Blogging is one of the most...
The liquidity crisis of the SME triggers the race of the Italian fintech companies
The pandemic does not affect the fintech sector, which, on the contrary, is growing. While large money management and insurtech...
The talent crowdfunding of Smartika to finance the studies of young people is starting
Smartika has recently launched a talent crowdfunding campaign. To operate in this area, the peer-to-peer lending company Smartika has signed...
Africa7 days ago
The Burkinabe cotton industry is in full development
Business6 days ago
Why small caps and value stocks appear to be now outperforming
Biotech5 days ago
Novartis invests $1.35 billion into a drug also designed for COVID-19
Featured6 days ago
77% of the companies in the Confidi network have started fintech projects